Verastem Inc (VSTM)
3.93
+0.14
(+3.69%)
USD |
NASDAQ |
Nov 21, 16:00
3.925
0.00 (0.00%)
After-Hours: 20:00
Verastem Enterprise Value: 123.54M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 123.54M |
| November 20, 2024 | 117.31M |
| November 19, 2024 | 124.88M |
| November 18, 2024 | 118.65M |
| November 15, 2024 | 126.21M |
| November 14, 2024 | 132.45M |
| November 13, 2024 | 131.11M |
| November 12, 2024 | 144.46M |
| November 11, 2024 | 147.13M |
| November 08, 2024 | 124.43M |
| November 07, 2024 | 108.86M |
| November 06, 2024 | 120.87M |
| November 05, 2024 | 115.09M |
| November 04, 2024 | 105.66M |
| November 01, 2024 | 106.46M |
| October 31, 2024 | 100.02M |
| October 30, 2024 | 99.21M |
| October 29, 2024 | 93.58M |
| October 28, 2024 | 85.12M |
| October 25, 2024 | 76.67M |
| October 24, 2024 | 81.10M |
| October 23, 2024 | 80.69M |
| October 22, 2024 | 86.33M |
| October 21, 2024 | 92.37M |
| October 18, 2024 | 67.81M |
| Date | Value |
|---|---|
| October 17, 2024 | 55.73M |
| October 16, 2024 | 82.71M |
| October 15, 2024 | 74.65M |
| October 14, 2024 | 69.42M |
| October 11, 2024 | 68.21M |
| October 10, 2024 | 68.61M |
| October 09, 2024 | 69.42M |
| October 08, 2024 | 66.20M |
| October 07, 2024 | 63.78M |
| October 04, 2024 | 64.19M |
| October 03, 2024 | 60.16M |
| October 02, 2024 | 65.80M |
| October 01, 2024 | 62.17M |
| September 30, 2024 | 69.02M |
| September 27, 2024 | 86.89M |
| September 26, 2024 | 83.67M |
| September 25, 2024 | 84.47M |
| September 24, 2024 | 86.48M |
| September 23, 2024 | 88.90M |
| September 20, 2024 | 94.53M |
| September 19, 2024 | 92.52M |
| September 18, 2024 | 87.69M |
| September 17, 2024 | 90.51M |
| September 16, 2024 | 88.50M |
| September 13, 2024 | 91.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.29M
Minimum
Oct 20 2022
732.38M
Maximum
Jun 21 2021
189.70M
Average
155.71M
Median
May 31 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.273M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.97M |
| Total Expenses (Quarterly) | 37.03M |
| EPS Diluted (Quarterly) | -0.60 |
| Earnings Yield | -81.42% |
| Normalized Earnings Yield | -85.24 |